New hope for reducing dangerous choking episodes in vulnerable children
NCT ID NCT05455359
Summary
This study aims to see which of two existing medications works better to reduce coughing, choking, and lung infection symptoms in children and young adults with neurological conditions who are fed through a tube. Researchers will compare prucalopride (a motility drug) to famotidine (an acid reducer) over ten weeks. The goal is to improve quality of life by easing these distressing and potentially dangerous symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.